Recruiting at 1 site No phase Type 2 Diabetes

Clinical trial for Type 2 Diabetes

Official title Outcomes-Based Health Program for Type 2 Diabetes

ClinicalTrials.gov ID: NCT07322757

What this study is testing

What it's testing
Type 2 diabetes is a growing health concern worldwide, influenced by genetic factors, overweight, metabolic syndrome, and insufficient physical activity.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 35 to 74

You may be able to join if

  • Type 2 diabetes diagnosed
  • diagnosed coronary artery disease,
  • diagnosed periferal artery disease,
  • diagnosed heart failure,
  • diagnosed diabetic renal disease (GFR \<60 OR uACR ≥ 3 for at least three months),

You likely can't join if

  • eGFR \< 30
  • uACR \> 200
  • BMI \> 50
  • heart ejection fraction EF \< 30
  • active cancer or less than five years from cancer treatment at enrollment
  • blindness in both eyes
See the full eligibility criteria
Who can join
  • Type 2 diabetes diagnosed
  • diagnosed coronary artery disease,
  • diagnosed periferal artery disease,
  • diagnosed heart failure,
  • diagnosed diabetic renal disease (GFR \<60 OR uACR ≥ 3 for at least three months),
  • diagnosed diabetic retinopathy,
  • previous stroke,
  • diagnosed atrial fibrillation or atrial flutter,
  • smoker
  • uses antihypertensive medication or systolic blood pressure \>140 mmHg or diastolic blood pressure \> 80 mmHg,
  • uses lipid lowering medication or LDL-cholesterol \> 2.6 or
  • BMI \> 25
What rules you out
  • eGFR \< 30
  • uACR \> 200
  • BMI \> 50
  • heart ejection fraction EF \< 30
  • active cancer or less than five years from cancer treatment at enrollment
  • blindness in both eyes
  • severe psychotic depression
  • inability to utilize digital applications

The study team makes the final eligibility decision.

Where it is enrolling

  • Kuopio, Northern Savonia, Finland

Compensation & support

This study's listing mentions compensation or reimbursement.

No amount is published here because ClinicalTrials.gov has no reliable field for payment or travel support. Ask the study team what's actually covered (payment for your time, travel, parking, or other study costs), and never join a trial for the compensation alone.

Questions & answers

Do participants get paid in this trial?

This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team, so confirm the details with them.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 35 years to 74 years. The study team makes the final eligibility decision.

Where is this trial taking place?

This study is enrolling now at Kuopio, Northern Savonia, Finland. Enter your location above to see the nearest enrolling site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.